Commentary: Nonspecific Protein Binding versus Membrane Partitioning: It Is Not Just Semantics
暂无分享,去创建一个
[1] M. Niemi,et al. Membrane transporters in drug development , 2010, Nature Reviews Drug Discovery.
[2] C. D. Francesco,et al. Membrane lipids as intracellular binders of chlorpromazine and related drugs. , 1977, Chemico-biological interactions.
[3] J. Axelrod. The enzymatic conversion of codeine to morphine. , 1955, The Journal of pharmacology and experimental therapeutics.
[4] D. Greenblatt,et al. Microsomal protein concentration modifies the apparent inhibitory potency of CYP3A inhibitors. , 2002, Drug metabolism and disposition: the biological fate of chemicals.
[5] M. Bickel,et al. Interactions of chlorpromazine and imipramine with artificial membranes investigated by equilibrium dialysis, dual-wavelength photometry, and fluorimetry. , 1979, Biochemical pharmacology.
[6] M. Hennessy,et al. A primer on the mechanics of P-glycoprotein the multidrug transporter. , 2007, Pharmacological research.
[7] Ying Zhang,et al. In Silico Modeling of Nonspecific Binding to Human Liver Microsomes , 2008, Drug Metabolism and Disposition.
[8] J. Axelrod. The enzymatic deamination of amphetamine (benzedrine). , 1955, The Journal of biological chemistry.
[9] Sagar Agarwal,et al. Breast cancer resistance protein and P-glycoprotein in brain cancer: two gatekeepers team up. , 2011, Current pharmaceutical design.
[10] I. Pastan,et al. Genetic analysis of the multidrug transporter. , 1995, Annual review of genetics.
[11] J Brian Houston,et al. BINDING OF DRUGS TO HEPATIC MICROSOMES: COMMENT AND ASSESSMENT OF CURRENT PREDICTION METHODOLOGY WITH RECOMMENDATION FOR IMPROVEMENT , 2006, Drug Metabolism and Disposition.
[12] Michael Gertz,et al. Hepatocellular Binding of Drugs: Correction for Unbound Fraction in Hepatocyte Incubations Using Microsomal Binding or Drug Lipophilicity Data , 2008, Drug Metabolism and Disposition.
[13] C. de Duve,et al. A short history of tissue fractionation , 1981, The Journal of cell biology.
[14] B. Alberts,et al. Intracellular Compartments and Protein Sorting , 2002 .
[15] M. Bickel,et al. Binding of basic and acidic drugs to rat tissue subcellular fractions. , 1974, Chemico-biological interactions.
[16] R. Austin,et al. A UNIFIED MODEL FOR PREDICTING HUMAN HEPATIC, METABOLIC CLEARANCE FROM IN VITRO INTRINSIC CLEARANCE DATA IN HEPATOCYTES AND MICROSOMES , 2005, Drug Metabolism and Disposition.
[17] R. Obach,et al. Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes. , 1999, Drug metabolism and disposition: the biological fate of chemicals.
[18] J. Cooper,et al. Detoxication of drugs and other foreign compounds by liver microsomes. , 1955, Science.
[19] I. Hidalgo,et al. Models to Predict Unbound Intracellular Drug Concentrations in the Presence of Transporters , 2012, Drug Metabolism and Disposition.
[20] C. Hansch. Quantitative approach to biochemical structure-activity relationships , 1969 .
[21] J. Mönkkönen,et al. Drug adsorption to plastic containers and retention of drugs in cultured cells under in vitro conditions. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[22] Scott L Cockroft,et al. The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties. , 2002, Drug metabolism and disposition: the biological fate of chemicals.
[23] H. Waterbeemd,et al. Pharmacokinetics and Metabolism in Drug Design: SMITH:PHARMACOKINETICS 3E O-BK , 2012 .
[24] M. Bickel,et al. Experimental errors resulting from uptake of lipophilic drugs by soft plastic materials. , 1970, Biochemical pharmacology.
[25] K. Skubitz. P-glycoprotein and multidrug resistance. , 1990, American journal of clinical pathology.
[26] Rebecca C Wade,et al. The ins and outs of cytochrome P450s. , 2007, Biochimica et biophysica acta.
[27] P. Janmey,et al. Biophysical properties of lipids and dynamic membranes. , 2006, Trends in cell biology.
[28] T. Österberg,et al. Chromatographic retention of drug molecules on immobilised liposomes prepared from egg phospholipids and from chemically pure phospholipids. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[29] L. Benet,et al. IN VITRO AND IN VIVO CORRELATION OF HEPATIC TRANSPORTER EFFECTS ON ERYTHROMYCIN METABOLISM: CHARACTERIZING THE IMPORTANCE OF TRANSPORTER-ENZYME INTERPLAY , 2006, Drug Metabolism and Disposition.
[30] P. Siekevitz,et al. ENZYME-STRUCTURE RELATIONSHIPS IN THE ENDOPLASMIC RETICULUM OF RAT LIVER , 1962, The Journal of cell biology.
[31] R. Obach,et al. Impact of nonspecific binding to microsomes and phospholipid on the inhibition of cytochrome P4502D6: implications for relating in vitro inhibition data to in vivo drug interactions. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[32] R. Obach,et al. Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol. , 1997, Drug metabolism and disposition: the biological fate of chemicals.
[33] K. Pang,et al. Interplay of transporters and enzymes in the Caco‐2 cell monolayer: I. effect of altered apical secretion , 2010, Biopharmaceutics & drug disposition.
[34] R. Austin,et al. The effect of ionized species on microsomal binding. , 2012, European journal of medicinal chemistry.